Study on Vascular Dysfunction: Comparing Acetylcholine Chloride and Carbachol for Forearm Blood Flow Evaluation in Patients

2 1 1 1

What is this study about?

This clinical trial is focused on studying *vascular dysfunction*, which refers to problems with blood vessels that can affect blood flow. The study is investigating two treatments: *carbachol* and *acetylcholine chloride*. These are substances used to help understand how blood flows in the forearm. The purpose of the study is to see if *carbachol* is as effective as *acetylcholine chloride* in measuring blood flow in the forearm.

Participants in the study will receive either *carbachol* or *acetylcholine chloride* through a method called *intraocular instillation solution*, which involves applying the solution directly to the eye. The study will use a technique called *plethysmography* to measure blood flow. This method involves gently restricting blood flow in the arm to see how well the blood vessels work. The study aims to compare the effects of the two substances on blood flow.

The study will take place over a short period, with participants receiving the treatment and having their blood flow measured. The goal is to gather information on how these substances affect blood flow, which could help in understanding and treating *vascular dysfunction* in the future. Participants will not be informed about whether they are receiving *carbachol*, *acetylcholine chloride*, or a placebo during the study.

1 initial visit

Upon joining the study, you will attend an initial visit. During this visit, your eligibility will be confirmed based on criteria such as age, health status, and body mass index (BMI).

You will be informed about the study’s purpose, which is to assess the effectiveness of two substances, carbachol and acetylcholine, in measuring blood flow in the forearm.

2 medication administration

You will receive an intraocular instillation solution containing either carbachol or acetylcholine chloride. This solution is administered directly into the eye.

The purpose of this administration is to evaluate the blood flow in your forearm using a method called plethysmography, which measures changes in volume within an organ or whole body.

3 monitoring and assessment

After the medication is administered, your forearm blood flow will be monitored. This involves measuring both relative and absolute blood flow to assess the effectiveness of the substances.

The monitoring process is non-invasive and aims to provide data on how well the substances work in evaluating blood flow.

4 follow-up visits

You may be required to attend follow-up visits to monitor any changes or effects resulting from the medication.

These visits are important to ensure your safety and to gather additional data for the study.

5 completion of study

The study is expected to conclude by May 1, 2025. Upon completion, you will be informed about the study’s findings and any relevant information regarding your participation.

Your contribution to the study will help in understanding the effectiveness of carbachol and acetylcholine in measuring blood flow.

Who Can Join the Study?

Must be a healthy man or woman.
Age must be between 18-40 years.
If you are a woman who can have children, you must use contraceptive treatment (methods to prevent pregnancy).
Your Body Mass Index (BMI) must be between 18.5-30 kg/m². BMI is a measure that uses your height and weight to work out if your weight is healthy.

Who Cannot Join the Study?

Patients with vascular dysfunction cannot participate. This means if you have problems with your blood vessels, you may not be eligible.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name	City	Country	Status
Region Midtjylland	Aarhus	Denmark

Trial status

Country	Status	Recruitment Start
Denmark	Not recruiting	02.05.2023

Trial locations

Investigated drugs:

Acetylcholine is a medication used in this study to help measure blood flow in the forearm. It works by causing blood vessels to widen, which increases blood flow. This helps researchers understand how well blood is moving through the forearm and can be used to compare with other medications.

Carbachol is another medication used in the study to measure blood flow in the forearm, similar to acetylcholine. It also causes blood vessels to widen, which helps increase blood flow. The study aims to see if carbachol is as effective as acetylcholine in evaluating blood flow in the forearm.

Investigated diseases:

Cardiovascular disorder

Vascular dysfunction – Vascular dysfunction refers to the impaired function of blood vessels, which can affect the regulation of blood flow and pressure. It often involves the endothelium, the inner lining of blood vessels, which plays a crucial role in maintaining vascular health. When the endothelium is damaged or not functioning properly, it can lead to reduced vasodilation, increased inflammation, and a higher risk of blood clot formation. Over time, these changes can contribute to the development of various cardiovascular conditions. The progression of vascular dysfunction can vary, but it generally involves a gradual worsening of blood vessel function. This condition can affect different parts of the body, leading to symptoms depending on the specific vessels involved.

Trial ID:

2023-503908-87-00

Trial Phase:

Therapeutic exploratory (Phase II)

Other Trials to Consider

#1 Clinical Trials Search in Europe

Study on Vascular Dysfunction: Comparing Acetylcholine Chloride and Carbachol for Forearm Blood Flow Evaluation in Patients

What is this study about?

Who Can Join the Study?

Who Cannot Join the Study?